Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Burkhoff

Showing results (411-420 of 484) with videos related to

Pageof 49
Sort By:
American Heart Journal|February 15, 2011
A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failureAlan Kadish, Koonlawee Nademanee, Kent Volosin, et al.
Circulation. Heart Failure|January 10, 2022
Intermittent Occlusion of the Superior Vena Cava to Improve Hemodynamics in Patients With Acutely Decompensated Heart Failure: The VENUS-HF Early Feasibility StudyNavin K Kapur, Michael S Kiernan, Irakli Gorgoshvili, et al.
European Journal of Heart Failure|April 1, 2026
Machine Learning-Based Phenotypes Combined with Comorbidity Burden in Cardiogenic ShockJonas Sundermeyer, Elric Zweck, Song Li, et al.
Journal of the American Heart Association|August 13, 2021
Pacemaker-Based Cardiac Neuromodulation Therapy in Patients With Hypertension: A Pilot StudyZbigniew Kalarus, Béla Merkely, Petr Neužil, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 27, 2025
Clinical outcomes of cardiogenic shock patients supported with VA-ECMO: Insights from the Cardiogenic Shock Working GroupJaime Hernandez-Montfort, Kevin J John, Daniel Goldstein, et al.
Journal of Cardiac Failure|May 26, 2026
Thiazides attenuate the diuretic response to Pecavaptan, a dual vasopressin receptor antagonist, in hospitalized heart failure patientsDaan C H Ceelen, Geert H D Voordes, Lucija Cosic, et al.
European Journal of Heart Failure|April 22, 2021
Splanchnic nerve modulation in heart failure: mechanistic overview, initial clinical experience, and safety considerationsMarat Fudim, Piotr P Ponikowski, Daniel Burkhoff, et al.
Journal of Cardiac Failure|August 24, 2019
Discordance Between Clinical Assessment and Invasive Hemodynamics in Patients With Advanced Heart FailureNikhil Narang, Ben Chung, Ann Nguyen, et al.
Journal of Cardiac Failure|March 4, 2026
Prognostic value of hemodynamic indices prior to tMCS explantation: An analysis from the Cardiogenic Shock Working GroupChristian Said, Jaime Hernandez-Montfort, Jonas Sundermeyer, et al.
European Journal of Heart Failure|May 22, 2022
Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: early results of the REBALANCE-HF trial roll-in cohortMarat Fudim, Peter S Fail, Sheldon E Litwin, et al.
Pageof 49

Showing results (411-420 of 484) with videos related to

Sort By:
Pageof 49
American Heart Journal|February 15, 2011
A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failureAlan Kadish, Koonlawee Nademanee, Kent Volosin, et al.
Circulation. Heart Failure|January 10, 2022
Intermittent Occlusion of the Superior Vena Cava to Improve Hemodynamics in Patients With Acutely Decompensated Heart Failure: The VENUS-HF Early Feasibility StudyNavin K Kapur, Michael S Kiernan, Irakli Gorgoshvili, et al.
European Journal of Heart Failure|April 1, 2026
Machine Learning-Based Phenotypes Combined with Comorbidity Burden in Cardiogenic ShockJonas Sundermeyer, Elric Zweck, Song Li, et al.
Journal of the American Heart Association|August 13, 2021
Pacemaker-Based Cardiac Neuromodulation Therapy in Patients With Hypertension: A Pilot StudyZbigniew Kalarus, Béla Merkely, Petr Neužil, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 27, 2025
Clinical outcomes of cardiogenic shock patients supported with VA-ECMO: Insights from the Cardiogenic Shock Working GroupJaime Hernandez-Montfort, Kevin J John, Daniel Goldstein, et al.
Journal of Cardiac Failure|May 26, 2026
Thiazides attenuate the diuretic response to Pecavaptan, a dual vasopressin receptor antagonist, in hospitalized heart failure patientsDaan C H Ceelen, Geert H D Voordes, Lucija Cosic, et al.
European Journal of Heart Failure|April 22, 2021
Splanchnic nerve modulation in heart failure: mechanistic overview, initial clinical experience, and safety considerationsMarat Fudim, Piotr P Ponikowski, Daniel Burkhoff, et al.
Journal of Cardiac Failure|August 24, 2019
Discordance Between Clinical Assessment and Invasive Hemodynamics in Patients With Advanced Heart FailureNikhil Narang, Ben Chung, Ann Nguyen, et al.
Journal of Cardiac Failure|March 4, 2026
Prognostic value of hemodynamic indices prior to tMCS explantation: An analysis from the Cardiogenic Shock Working GroupChristian Said, Jaime Hernandez-Montfort, Jonas Sundermeyer, et al.
European Journal of Heart Failure|May 22, 2022
Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: early results of the REBALANCE-HF trial roll-in cohortMarat Fudim, Peter S Fail, Sheldon E Litwin, et al.
Pageof 49